Oncolytics Biotech, Inc. (ONCY)
0.85
+0.01
(+0.82%)
USD |
NASDAQ |
Aug 24, 16:00
0.85
0.00 (0.00%)
After-Hours: 20:00
Oncolytics Biotech Total Assets (Quarterly) : 7.671M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.671M |
| March 31, 2026 | 8.161M |
| December 31, 2025 | 7.582M |
| September 30, 2025 | 11.22M |
| June 30, 2025 | 13.97M |
| March 31, 2025 | 13.69M |
| December 31, 2024 | 13.42M |
| September 30, 2024 | 17.96M |
| June 30, 2024 | 23.44M |
| March 31, 2024 | 25.68M |
| December 31, 2023 | 29.44M |
| September 30, 2023 | 34.09M |
| June 30, 2023 | 24.16M |
| March 31, 2023 | 26.10M |
| December 31, 2022 | 27.55M |
| September 30, 2022 | 28.35M |
| June 30, 2022 | 31.19M |
| March 31, 2022 | 35.58M |
| December 31, 2021 | 36.32M |
| September 30, 2021 | 41.52M |
| June 30, 2021 | 45.47M |
| March 31, 2021 | 43.11M |
| December 31, 2020 | 26.96M |
| September 30, 2020 | 23.39M |
| June 30, 2020 | 25.41M |
| Date | Value |
|---|---|
| March 31, 2020 | 24.28M |
| December 31, 2019 | 15.16M |
| September 30, 2019 | 12.30M |
| June 30, 2019 | 11.71M |
| March 31, 2019 | 12.32M |
| December 31, 2018 | 10.88M |
| September 30, 2018 | 14.04M |
| June 30, 2018 | 15.73M |
| March 31, 2018 | 10.96M |
| December 31, 2017 | 14.49M |
| September 30, 2017 | 11.87M |
| June 30, 2017 | 13.54M |
| March 31, 2017 | 7.966M |
| December 31, 2016 | 11.00M |
| September 30, 2016 | 14.03M |
| June 30, 2016 | 16.45M |
| March 31, 2016 | 17.80M |
| December 31, 2015 | 19.71M |
| September 30, 2015 | 23.12M |
| June 30, 2015 | 26.58M |
| March 31, 2015 | 24.83M |
| December 31, 2014 | 14.84M |
| September 30, 2014 | 16.18M |
| June 30, 2014 | 18.82M |
| March 31, 2014 | 20.87M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
| Vicapsys Life Sciences, Inc. | 0.1325M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.84M |
| Shareholders Equity (Quarterly) | -6.167M |
| Debt to Equity Ratio | -0.0726 |
| Current Ratio | 1.353 |
| Net Debt Paydown Yield | 0.04% |